Innoviva, Inc.
INVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001080014
No open-market purchases or sales by Innoviva, Inc. insiders were filed in the last 90 days; 308 institutions reported holding it in 13F filings for Q2 2026, worth $1.71B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Innoviva, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Innoviva, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Zhen Marianne | Chief Accounting Officer | 56,389 | Aug 24, 2026 | 5 |
| Basso Stephen | Chief Financial Officer | 88,013 | Aug 24, 2026 | 6 |
| Raifeld Pavel | Chief Executive Officer | 284,799 | Aug 24, 2026 | 5 |
| Linden Josephine | Director | 15,194 | May 20, 2026 | 1 |
| Haimovitz Jules | Director | 152,692 | May 6, 2026 | 1 |
| Schlesinger Sarah J. | Director | 140,492 | May 6, 2026 | 1 |
| Small Derek A | Director | 45,035 | May 6, 2026 | 1 |
| DiPaolo Mark | Director | 140,492 | May 6, 2026 | 1 |
| Denner Alexander J | 10% Owner | 5,658,705Indirect | Mar 17, 2025 | 0 |
| Sarissa Capital Management LP | 10% Owner | 5,658,705Indirect | Mar 17, 2025 | 0 |
| Odysseas Kostas D | Director | 122,625 | Jun 20, 2024 | 0 |
| Srivastava Sapna | Director | 44,096 | Jun 20, 2024 | 0 |
| Ronsheim Matthew | See Remarks | 40,510 | May 21, 2024 | 0 |
| Koziel Margaret | Chief Medical Officer | – | Aug 2, 2023 | 0 |
| Birx Deborah | Director | 58,984 | May 24, 2023 | 0 |
| Bickerstaff George | Director | 137,207 | Apr 27, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2025 (view filing)9:30 PM ET | Mar 4-6 | 2 days | Denner Alexander J and 1 other10% Owner | SSaleCommon Stock, par value $0.01 per share | −1.62M | $17.55 | −$28.4M | −22.2%5.66M after | Amended3 lots |
| Nov 17, 2023 (view filing) | Nov 15 | 2 days | Zhen MarianneChief Accounting Officer | SSale | −11.0K | $13.99 | −$153.8K | −21.5%40.2K after | 2 lots |
| Jun 20, 2023 (view filing)9:00 PM ET | Jun 15 | 5 days | Denner Alexander J and 1 other10% Owner | PPurchaseCommon Stock, par value $0.01 per share | +62.0K | $13.13 | +$814.2K | +0.9%7.28M after | |
| Jun 7, 2023 (view filing)8:10 PM ET | Jun 5-6 | 2 days | Denner Alexander J and 1 other10% Owner | PPurchaseCommon Stock, par value $0.01 per share | +15.0K | $13.05 | +$195.7K | +0.2%7.21M after | 2 lots |
| May 30, 2023 (view filing)7:01 PM ET | May 25-30 | 5 days | Denner Alexander J and 1 other10% Owner | PPurchaseCommon Stock, par value $0.01 per share | +200.0K | $13.04 | +$2.61M | +2.9%7.20M after | 3 lots |
| May 19, 2023 (view filing)9:12 PM ET | May 17-19 | 2 days | Denner Alexander J and 1 other10% Owner | PPurchaseCommon Stock, par value $0.01 per share | +96.0K | $13.22 | +$1.27M | +1.4%7.00M after | Amended3 lots |
| May 15, 2023 (view filing)9:09 PM ET | May 11 | 4 days | Denner Alexander J and 1 other10% Owner | PPurchaseCommon Stock, par value $0.01 per share | +290.0K | $12.34 | +$3.58M | +4.4%6.90M after | |
| Mar 14, 2023 (view filing) | Mar 10 | 4 days | Raifeld PavelChief Executive Officer | PPurchase | +3.00K | $10.87 | +$32.6K | +44.1%9.80K after | |
| Aug 24, 2021 (view filing) | Aug 20 | 4 days | Zhen MarianneChief Accounting Officer | SSale | −1.13K | $15.89 | −$17.9K | −3.1%35.4K after | Amended |
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | Zhen MarianneChief Accounting Officer | SSale | −2.80K | $16.02 | −$44.9K | −7.1%36.5K after | Amended |